BofA upgraded Surgery Partners (SGRY) to Buy from Neutral with a $28 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGRY:
- TD says CMS hospital rules positive for Surgery Partners, negative for HCA
- Positive Outlook for Surgery Partners Amid CMS Regulatory Changes Boosting ASC Opportunities
- Surgery Partners Decides to Remain Independent
- Surgery Partners, Bain Capital conclude discussions
- Surgery Partners reaffirms FY25 revenue view $3.3B-$3.45B, consensus $3.38B